| PD-1 blockade in tumors with mismatch-repair deficiency DT Le, JN Uram, H Wang, BR Bartlett, H Kemberling, AD Eyring, ... New England Journal of Medicine 372 (26), 2509-2520, 2015 | 9615 | 2015 |
| Cancer genome landscapes B Vogelstein, N Papadopoulos, VE Velculescu, S Zhou, LA Diaz Jr, ... science 339 (6127), 1546-1558, 2013 | 8635 | 2013 |
| Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade DT Le, JN Durham, KN Smith, H Wang, BR Bartlett, LK Aulakh, S Lu, ... Science 357 (6349), 409-413, 2017 | 6129 | 2017 |
| A simplified system for generating recombinant adenoviruses TC He, S Zhou, LT Da Costa, J Yu, KW Kinzler, B Vogelstein Proceedings of the National Academy of Sciences 95 (5), 2509-2514, 1998 | 4853 | 1998 |
| Requirement for p53 and p21 to sustain G2 arrest after DNA damage F Bunz, A Dutriaux, C Lengauer, T Waldman, S Zhou, JP Brown, ... Science 282 (5393), 1497-1501, 1998 | 3616 | 1998 |
| Detection and localization of surgically resectable cancers with a multi-analyte blood test JD Cohen, L Li, Y Wang, C Thoburn, B Afsari, L Danilova, C Douville, ... Science 359 (6378), 926-930, 2018 | 2412 | 2018 |
| Human Smad3 and Smad4 are sequence-specific transcription activators L Zawel, J Le Dai, P Buckhaults, S Zhou, KW Kinzler, B Vogelstein, ... Molecular cell 1 (4), 611-617, 1998 | 1322 | 1998 |
| Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells J Yun, C Rago, I Cheong, R Pagliarini, P Angenendt, H Rajagopalan, ... Science 325 (5947), 1555-1559, 2009 | 1041 | 2009 |
| Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells K Kim, AD Skora, Z Li, Q Liu, AJ Tam, RL Blosser, LA Diaz Jr, ... Proceedings of the National Academy of Sciences 111 (32), 11774-11779, 2014 | 710 | 2014 |
| Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma M Li, H Zhao, X Zhang, LD Wood, RA Anders, MA Choti, TM Pawlik, ... Nature genetics 43 (9), 828-829, 2011 | 477 | 2011 |
| Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention AM Lennon, AH Buchanan, I Kinde, A Warren, A Honushefsky, AT Cohain, ... Science 369 (6499), eabb9601, 2020 | 472 | 2020 |
| Sensitive digital quantification of DNA methylation in clinical samples M Li, W Chen, N Papadopoulos, SN Goodman, NC Bjerregaard, ... Nature biotechnology 27 (9), 858, 2009 | 394 | 2009 |
| Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses NJ Roberts, L Zhang, F Janku, A Collins, RY Bai, V Staedtke, AW Rusk, ... Science translational medicine 6 (249), 249ra111-249ra111, 2014 | 387 | 2014 |
| Bacteriolytic therapy can generate a potent immune response against experimental tumors N Agrawal, C Bettegowda, I Cheong, JF Geschwind, CG Drake, ... Proceedings of the National Academy of Sciences 101 (42), 15172-15177, 2004 | 333 | 2004 |
| Characterization of human FAST-1, a TGFβ and activin signal transducer S Zhou, L Zawel, C Lengauer, KW Kinzler, B Vogelstein Molecular cell 2 (1), 121-127, 1998 | 306 | 1998 |
| Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers JX Caushi, J Zhang, Z Ji, A Vaghasia, B Zhang, EHC Hsiue, BJ Mog, ... Nature 596 (7870), 126-132, 2021 | 304 | 2021 |
| Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome V Staedtke, RY Bai, K Kim, M Darvas, ML Davila, GJ Riggins, ... Nature 564 (7735), 273-277, 2018 | 266 | 2018 |
| Targeting a neoantigen derived from a common TP53 mutation EHC Hsiue, KM Wright, J Douglass, MS Hwang, BJ Mog, AH Pearlman, ... Science 371 (6533), eabc8697, 2021 | 236 | 2021 |
| Targeted deletion of Smad4 shows it is required for transforming growth factor β and activin signaling in colorectal cancer cells S Zhou, P Buckhaults, L Zawel, F Bunz, G Riggins, J Le Dai, SE Kern, ... Proceedings of the National Academy of Sciences 95 (5), 2412-2416, 1998 | 220 | 1998 |
| Systemic use of tumor necrosis factor alpha as an anticancer agent NJ Roberts, S Zhou, LA Diaz Jr, M Holdhoff Oncotarget 2 (10), 739, 2011 | 215 | 2011 |
